ClinicalTrials.gov
public full text
Public Domain
Assessment of the Impact of Clinical Pharmacogenomics on Real and Potential Medication Use in Veterans
The purpose of this study is to assess the prevalence of veterans with major depressive disorder (MDD) who are being treated with a medication that has current Clinical Pharmacogenetics Implementation Consortium (CPIC) or Pharmacogenomics Knowledgebase (PharmGKB) actionable recommendations that have a pharmacogenomic variation that impacts the safety or efficacy of the subject medication.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Pharmacogenomic Inequalities: Strategies for Justice in Biomedical Research and Healthcare#719096
- Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)#966183
- Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study#224186
- McLean and Genomind Prospective Study#854480
- Psychiatric pharmacogenomics: from genetic evidence to clinical integration – structural, educational, and ethical challenges.#122838
Record · ID 902857
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive